France
Air Liquide, founded in 1902, is a global frontrunner in gases, technologies, and services, catering to industries and healthcare sectors. Headquartered in France, the company operates in 60 countries and employs around 66,500 individuals. It serves over 4 million customers and patients worldwide, focusing on essential molecules like oxygen, nitrogen, and hydrogen.
Rooted in innovation, Air Liquide's ADVANCE strategic plan emphasizes holistic growth by integrating financial and non-financial initiatives, significantly investing in climate and energy transition solutions, particularly hydrogen, while expanding in markets like healthcare and electronics.
The company's robust business model and technological expertise are matched by strong financial performance, exemplified by a revenue exceeding €27 billion in 2024. The recent Post-IPO Debt investment of €500 million in March 2025 reflects its ongoing strategic advancements. Listed on Euronext Paris and part of major indices like CAC 40 and EURO STOXX 50, the company demonstrates both stability and growth potential for investors.
